Daniel Gillen, PhD, Chancellor’s Professor and Chair of Statistics and the leader for the ADRC Data Management and Statistics Core was recently named a fellow of the American Association for…
阅读更多
新闻
The UC Irvine School of Medicine recognized the 2024 best mentors and Elizabeth Head, PhD, Professor and Vice Chair of Research in the Department of Pathology and Laboratory Medicine was…
阅读更多
For patients experiencing cognitive decline due to Alzheimer’s Disease (AD), choosing the most appropriate treatment course at the right time is of great importance. A key element to these decisions…
阅读更多
Jessica Noche, PhD, a postdoctoral scholar and REMIND co-chair recently published an article in the Journal of Neuroscience with UCI MIND faculty, Craig Stark, PhD, and Elizabeth Head, PhD, on…
阅读更多
As we celebrate Women’s History Month this March, we also find ourselves at a historic moment in scientific inquiry for women’s health research. Today, nearly two-thirds of Americans with Alzheimer’s…
阅读更多
Ahmad Sajjadi, MD, PhD, UCI Neurologist and UCI MIND faculty member, was quoted in Healthline regarding the recent announcement by FDA to delay the decision to approve Eli Lilly’s amyloid…
阅读更多
UCI MIND faculty member and UCI Neurologist, Ahmad Sajjadi, MD, PhD, awarded UCI Institute for Precision Health Pilot Award. Dr. Sajjadi will work with Tianchen Qian, PhD, a REC trainee…
阅读更多
The FDA today announced that it will convene an advisory panel to review the data submitted to support potential approval of donanemab, a monoclonal antibody against the beta amyloid protein…
阅读更多
Message from the Director Dear Friends of UCI MIND, Happy New Year! We hope that 2024 is off to a positive start for you. As we embark upon a new…
阅读更多
Ahmad Sajjadi, MD, PhD, a UCI Neurologist and UCI MIND faculty member was interviewed live on NBC Los Angeles about the recent announcement that talk show host Wendy Williams…
阅读更多
The LA Times recently published a fairly negative appraisal of the construct of preclinical Alzheimer’s disease (AD). The article described the recent effort by an international committee to update diagnostic…
阅读更多
Biogen, the maker of aducanumab has announced that it will terminate the Phase 4 trial required by the FDA for aducanumab, the monoclonal antibody against beta amyloid that received accelerated…
阅读更多
The medications have not been widely tested in Black people with the disease, underscoring stark — and persistent — disparities ABINGTON, Pa. — Wrapped in a purple blanket, Robert Williford…
阅读更多
Black people know intrinsically about the myriad of life areas negatively impacted by the fact that the myth of white supremacy is baked into the foundations of all American institutions.…
阅读更多
In the first study of its kind in humans, researchers have discovered that it is safe to use sound waves fired into specific areas of the brain to open a…
阅读更多
TAMPA (BLOOM) – Join us as we explore strategies—from mindful living to emerging technologies—and discover how every choice can lead to a longer and healthier life. Welcome to the science of…
阅读更多
UCI MIND Director, Dr. Joshua Grill, is quoted in Neurology Today for his work with colleagues at USC, Massachusetts General Hospital, Brigham and Women’s Hospital, and Eisai on racial and…
阅读更多
Dr. Joshua Grill, Director of UCI MIND is named one of Orange County’s 125 most influential people for 2023 by the Orange County Register! Read article here The post UCI…
阅读更多
UCI MIND faculty members, Drs. Mark Mapstone and Mark Fisher were recently quoted in a recent Rolling Stone article on the political divide between younger voters and aging legislators. Check…
阅读更多
Some people in their 80s and 90s show shockingly little decline in their brainpower. Scientists are beginning to understand what makes them different and how the rest of us might…
阅读更多